FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

WLF Post Looks at Pfizers Copay Subsidy Program

[ Price : $8.95]

Writing in an online Washington Legal Foundation post, Goodwin Procter partner Matt Wetzel examines a recent appeals court decisio...

FDA Approves Abbott Proclaim Plus System

[ Price : $8.95]

FDA approves Abbotts new Precision Plus spinal cord stimulation system.

BioMarin Refiling BLA for Hemophilia A Gene Therapy

[ Price : $8.95]

BioMarin Pharmaceutical says it will resubmit by the end of September its BLA for hemophilia A gene therapy Roctavian (valoctocoge...

Califf Says No Panel Will Review Covid Boosters

[ Price : $8.95]

FDA commissioner Robert Califf says there are no new questions on the recently submitted Covid-19 booster vaccines and the agency ...

Comments on Breakthrough Therapy Recission Draft

[ Price : $8.95]

Three stakeholders comment on an FDA draft guidance on rescinding breakthrough therapy designations.

Imbruvica Pediatric sNDA Approved by FDA

[ Price : $8.95]

FDA approves a Pharmacyclics supplemental NDA for Imbruvica (ibrutinib) for certain pediatric patients over one year of age with c...

FDA Releases 3 Drug Safety-Related Label Changes

[ Price : $8.95]

FDA publishes drug safety-related labeling changes for Gleevec and Rapamune.

House Committee on Trump's Covid Pressure on FDA

[ Price : $8.95]

A House Select Subcommittee on the Coronavirus Crisis report details evidence of what it sees as inappropriate Trump administratio...

Info Collection on Humanitarian Use Devices

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Medical Devices; Humanitarian Use Devices (H...

Device Labeling Info Collection

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection revision entitled Medical Device Labeling Regulations.